Evidence map›Paper›PMID 7535332›Full record

ArticleThe Journal of experimental medicine1995

Facultative role of germinal centers and T cells in the somatic diversification of IgVH genes.

C Miller, J Stedra, G Kelsoe, J Cerny

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Studies of the humoral immune response.Immunologic research · 2000
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

C MillerDepartment of Microbiology and Immunology, School of Medicine, University of Maryland at Baltimore 21201, USA.
J Stedra
G Kelsoe
J Cerny
University of Maryland, Baltimore · US

Funding

MURINE ANTIBODY REPERTOIRER01AI024335 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI KELSOE, GARNETT H · 1988 to 2010
$2.7M
REPERTOIRE OF BACTERIAL ANTIBODY IN AGINGR01AG008193 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI CERNY, JAN · 1988 to 1996
–
NIAID NIH HHS AI24335NIA NIH HHS AG08193
6 · The paper itself

Abstract

The development of memory B cells takes place in germinal centers (GC) of lymphoid follicles where antigen-driven lymphocytes undergo somatic hypermutation and affinity selection, presumably under the influence of helper T cells. However, the mechanisms that drive this complex response are not well understood. We explored the relationship between GC formation and the onset of hypermutation in response to the hapten phosphorylcholine (PC) coupled to antigenic proteins in mice bearing different frequencies of CD4+ T cells. PC-reactive GC were identified by staining frozen splenic sections with peanut agglutinin (PNA) and with monoclonal Abs against AB1-2, a dominant idiotope of T15+ anti-PC antibody. The nucleotide sequences of rearranged T15 VH1 genes were determined from polymerase chain reaction amplifications of genomic DNA from microdissected GC B cells. T15+ GC became fully developed by day 6-7 after primary immunization of euthymic mice with either PC-keyhole limpet hemocyanin (KLH) or PC-chicken gamma globulin (CGG). Yet the VH1 gene segments recovered from the primary GC as late as day 10-14 had low numbers of mutations, in contrast to responses to the haptens nitrophenyl or oxazolone that sustain high levels of hypermutation after GC formation. PC-reactive B cells proliferate in histologically typical GC for considerable periods with no or little somatic hypermutation; the signals for GC formation are independent of those for the activation of hypermutation. We then examined GC 7 d after secondary immunization with PC-KLH in euthymic mice, in nu/nu mice reconstituted with limited numbers of normal CD4+ cells before priming (CD4(+)-nu/nu) and in nu/nu mice. All of these animals develop T15+ GC after antigen priming, however, the patterns of V gene mutations in the secondary GC reflected the levels of CD4+ cells present during the primary response. VDJ sequences from secondary GC of euthymic mice were heavily mutated, but most of these mutations were shared among all related (identical VDJ joints) sequences suggesting the proliferation of mutated, memory B cells, with little de novo somatic hypermutation. In contrast, the patterns of V gene diversity in secondary GC from CD4(+)-nu/nu mice suggested that there was ongoing mutation and clonal diversification during the first week after rechallenge. The secondary GC from T cell-deficient, nu/nu mice showed little evidence for mutational and/or recombinational diversity of T15+ B cells. We conclude that the participation of CD4+ helper cells is required for full activation of the mutator in GC and takes place in a dose-dependent fashion.

Indexed as

Gene Rearrangement, B-Lymphocyte, Heavy ChainGenes, ImmunoglobulinAmino Acid SequenceAnimalsAntibody DiversityBase SequenceB-LymphocytesChickensgamma-GlobulinsHaptensHemocyaninsImmunizationImmunization, SecondaryImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionImmunologic Memory4-hydroxy-5-nitrophenyl acetic acidgamma-GlobulinsHaptensHemocyaninsImmunoglobulin Heavy ChainsImmunoglobulin Variable Regionkeyhole-limpet hemocyaninNitrophenolsOxazolonePhenylacetatesPhosphorylcholine

Identifiers

PMID7535332
PMCPMC2191948
OpenAlexW2131600504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.